What You Should Know
- U.S. Health IT M&A and buyout volume rebounded in Q2 2026 to 121 announced transactions after averaging 101 transactions across Q4 2025 and Q1 2026, according to Healthcare Growth Partners’ July 2026 Health IT Market Review report.
- The HGP Health IT Revenue Multiple recovered to 4.7x revenue by the end of Q2 2026 after dropping from 5.3x down to 3.7x in April.
- Health IT demonstrated strong resilience during the “SaaSpocalypse,” outperforming broader Enterprise SaaS revenue multiples that compressed to 3.1x before rebounding to ~4.0x.
- Private equity exit backlogs persist because fewer than 60% of Health IT buyouts completed in 2018 and 2019 have been realized, extending median hold periods beyond five years.
- Capital deployment reached an annualized rate of $13 billion in 1H 2026, with extreme value concentration as the 20 largest financings captured ~56% of total U.S. invested capital.
- AI is driving a “second growth act” for incumbent Health IT platforms, with established platforms capturing 68% of capital across the top 20 financings compared to 32% for AI-native startups.
M&A Volume, Multiples, and Subsector Performance
The data compiled in HGP’s proprietary database highlights a clear trajectory of recovery following a subdued Q1 2026. U.S. Health IT M&A and buyout activity grew from an average of 101 transactions per quarter across Q4 2025 and Q1 2026 up to 121 announced deals in Q2 2026.
Parallel to transaction volume, the 6-month moving average HGP Revenue Multiple climbed back to 4.7x revenue by June 30, 2026, recovering from its April low of 3.7x.
At the subsector level, valuation distributions reflect investor preferences for high-margin, clinically essential, or AI-accelerated platforms:
- Analytics (6.7x Median Revenue Multiple): Leads all subsectors, driven by demand for life sciences data, predictive clinical analytics, and AI-enabled decision engines.
- Patient & Provider Communications (6.0x Median Revenue Multiple): Supported by a new wave of AI-native scheduling, intake, and patient engagement tools.
- Revenue Cycle Management (RCM) Tech (6.0x Median Revenue Multiple): Retains high strategic value due to immediate hospital ROI and automated billing efficiency.
- Infrastructure Tech (5.3x Median Revenue Multiple): Captures steady interest across resource management, compliance, and clinical workflow platforms.
- PM / EMR Systems (4.6x Median Revenue Multiple): Sustains stable valuations as core systems of record integrate ambient AI scribes and automated charting.
Private Equity Analysis: Unpacking the DPI and Portfolio Exit Backlog
A central theme of the July 2026 HGP report is the persistent private equity exit backlog. Despite record Health IT buyout exits in 2024 and 2025, sponsor portfolio inventory continues to accumulate.
HGP’s vintage analysis disproves the common belief that this overhang was created by a surge in COVID-era buyouts. Instead, buyouts during 2020–2022 were actually lower than the active 2018–2019 period.
The primary driver of today’s backlog is a structural extension of realization timelines. The median hold period for Health IT assets has stretched from 3.5–4.0 years pre-COVID to over 5.0 years in 2026.
Fewer than 60% of buyouts completed in 2018 and 2019 have been realized to date. Because entry multiples during peak years were elevated, sponsors are delaying exits until earnings growth and credit market stability align to hit required return thresholds.
For more information, visit https://hgp.com/research-news/hgp-releases-its-july-2026-health-it-market-review/
